ReviewNuclear retinoid receptors and the transcription of retinoid-target genes
Introduction
Vitamin A and its active derivatives referred to as retinoids are non-steroid hormones which play a critical role in the development and homeostasis of virtually every vertebrate tissues through their regulatory effects on cell differentiation, proliferation and apoptosis Ross et al., 2000, Altucci and Gronemeyer, 2001a. It has long been established that retinoids exert their action by regulating the expression of specific subsets of genes within target tissues. However, it is only during the last 15 years that the understanding for retinoids action rapidly increased, subsequently to the cloning of nuclear retinoid receptors and the identification, within the promoters of retinoid-responsive genes, of elements exhibiting a high affinity for these receptors (for review, see Chambon, 1996, Laudet and Gronemeyer, 2001, and references therein). Then these nuclear receptors have been shown to work as ligand-activated transcription activators in a spatiotemporal specific manner during embryonic development.
During the last decade, the molecular rationale for retinoid receptors action has been facilitated by the identification of the DNA- and ligand-binding domains (DBD and LBD, respectively) (Chambon, 1996), and by the determination of their crystal structure (Renaud and Moras, 2000). Moreover, a number of studies demonstrated that they have to contend with repressive chromatin structures in order to activate gene expression. Indeed, as most target genes are initially silent and packed in a dense chromatin structure, liganded retinoid receptors recruit a battery of intermediary proteins, including coactivators, chromatin remodellers and modifyers which act in a coordinated and/or combinatorial manner to decompact chromatin and direct RNA polymerase II (RNA Pol II) and the general transcription factors (GTFs) to the promoter (Dilworth and Chambon, 2001).
Then an important question was what happens after the retinoid-activated receptors have bound their DNA reponse elements and recruited the transcription machinery. Now, there is increasing evidence that the ubiquitin–proteasome machinery degrades the retinoid receptors subsequently to their activation Zhu et al., 1999, Boudjelal et al., 2000, Kopf et al., 2000, Gianni et al., 2002a. This degradation process may either disrupt the transcription initiation complex, allowing elongation to proceed, and/or terminate the response to retinoids in order to allow rapidly other transcriptional programs.
Finally, the last years have witnessed a new way of regulation of retinoid receptors. Indeed, ongoing studies revealed that they can integrate multiple signaling pathways through their phosphorylation (Rochette-Egly, 2003). Alternatively, retinoids cross-talk with a number of signaling pathways. All these processes converge towards finely tuned transcriptional control.
This review will describe our current knowledge about the molecular mechanisms through which retinoid receptors regulate transcription, ranging from DNA binding, dynamics of ligand binding and chromatin remodeling and finally to their degradation. It will also focus on how sequential and/or coordinated phosphorylation events regulate their functionality.
Section snippets
Retinoid receptors contain a DNA-binding domain and two activation functions AF-1 and AF-2
The retinoid signal is transduced by two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which work as RXR/RAR heterodimers Kastner et al., 1997, Mark et al., 1999. Each family consists of three isotypes (α, β and γ) encoded by separate genes Leid et al., 1992, Mangelsdorf and Evans, 1995, Chambon, 1996. RARs are activated by all-trans retinoic acid (RA) and its 9-cis isomer, while RXRs are only activated by 9-cis RA. For each isotype,
First step: retinoid receptors binding to responsive elements located in the regulatory sequences of target genes
In the absence of ligand, retinoid receptors are found primarily in the nucleus. They bind as asymetric, oriented RAR/RXR heterodimers to specific DNA sequences or RA response elements (RAREs) composed typically of two direct repeats of a core hexameric motif, PuG(G/T)TCA Leid et al., 1992, Mangelsdorf and Evans, 1995 (Fig. 4A). The classical RARE is a 5-bp-spaced direct repeat (referred to as DR5). However, RAR/RXR heterodimers also bind to direct repeats separated by 1 bp (DR1) or 2 bp (DR2).
Second step: ligand binding, coactivators recruitment and chromatin decompaction
When genes are silent, DNA is packaged into a highly organized and compact nucleoprotein structure known as chromatin which impedes all the transcription steps. The basic unit of chromatin is the nucleosome which consists of DNA wrapped around a protein core containing two copies each of four histone proteins. Protruding from the nucleosomes are the N-terminal «tails» of the core histones whose interaction with DNA can be modulated upon covalent modifications (acetylation, phosphorylation,
Third step: recruitment of the transcriptional machinery
Once repressive chromatin has been decondensed, it has been proposed that a coregulators exchange occurs, in order to allow the RARE-bound heterodimers to participate in the entry of RNA-Pol II and GTFs into the preinitiation complex Chen et al., 1999b, Malik and Roeder, 2000. The current working hypothesis is that the p160 coactivators dissociate, subsequent to their acetylation which decreases their ability to interact with the receptors (Chen et al., 1999b), or to their degradation by the
Control of RAR/RXR transactivation by the ubiquitin–proteasome system
In recent years, it has become evident that the transcriptional activity of retinoid receptors, as that of most transcription factors, is also regulated by the ubiquitin–proteasome pathway. Paradoxically, both the proteolytic and non-proteolytic activities of this system appear to modulate transcription at different levels Ferdous et al., 2001, Salghetti et al., 2001, Tansey, 2001, Conaway et al., 2002, Muratani and Tansey, 2003.
One main role of the ubiquitin–proteasome system is to degrade
Regulation of RAR/RXR-mediated transcription through phosphorylation
RARs and RXRs are substrates for a multitude of kinases (see Fig. 1, Fig. 6) (Rochette-Egly, 2003). Importantly, subsequent to their interaction with TFIIH, RARs (RARα and RARγ) are phosphorylated in their N-terminal A/B region by the cdk7 subunit of TFIIH which has a cyclin-dependent kinase activity Rochette-Egly et al., 1997, Bastien et al., 2000. This phosphorylation process which has been extensively studied, especially in the case of RARα, plays a critical role in the retinoid response.
Retinoid receptors cross-talk with other signaling pathways
Due to the ability of RXRs to serve as heterodimeric partners not only to RARs, but also to several other nuclear receptors (PPARs, LXR) (Willy and Mangelsdorf, 1999), it is evident that retinoids can also control, the transcription of a wider set of hormone-responsive genes Leid et al., 1992, Mangelsdorf and Evans, 1995, Chambon, 1996. Moreover, one has to consider that, as is true for many other genes, the promoters of retinoid-target genes contain, in addition to the cognate response
Conclusion and perspectives
Retinoids are essential for the control of normal cell differentiation and proliferation. Therefore they are morphogens and essential regulators of embryogenesis. In adults, they are required for the proper functioning of a number of organs. All these functions involve the transcriptional control of a large number of genes by RXR/RAR heterodimers, as gene-ablation experiments generate embryonic development defects and abrogate the differentiative and antiproliferative effects of RA.
According to
Acknowledgements
We are particularly grateful to Gaetan Bour and Emilie Gaillard for enthusiastic discussions and for critics. Many thanks also to all the past members of the group for their contribution to the work. We are also very grateful to Prof. P. Chambon for constant support. Our studies mentioned in the text have been supported by funds from the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé et de la Recherche Médicale (INSERM), the Hôpital Universitaire de
References (144)
- et al.
What does ‘chromatin remodeling’ mean?
Trends Biochem. Sci.
(2000) - et al.
Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma
Hepatology
(2002) - et al.
Hyperphosphorylation of the retinoid X receptor alpha (RXRa) by activated c-Jun N-terminal kinases (JNKs)
J. Biol. Chem.
(1999) - et al.
How does Pol II overcome the nucleosome barrier?
Mol. Cell
(2002) - et al.
Nuclear receptors in cell life and death
Trends Endocrinol. Metab.
(2001) - et al.
Synergy of SF1 and RAR in activation of Oct-3/4 promoter
J. Biol. Chem.
(2000) - et al.
TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7
J. Biol. Chem.
(2000) Histone modifications in transcriptional regulation
Curr. Opin. Genet. Dev.
(2002)- et al.
TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2
J. Biol. Chem.
(2002) - et al.
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
Mol. Cell
(2000)
Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells
Blood
Steroid/nuclear receptor coactivators
Vitam. Horm.
Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
Cell
Signaling to chromatin through histone modifications
Cell
Ordered recruitment: gene-specific mechanism of transcription activation
Mol. Cell
Signal transduction by the JNK group of MAP kinases
Cell
Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity
J. Biol. Chem.
The proteasome, a novel protease regulated by multiple mechanisms
J. Biol. Chem.
Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions. A novel mechanism of action for retinoid antagonists
J. Biol. Chem.
Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II
J. Biol. Chem.
All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs
Cell
Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR
J. Mol. Biol.
The 14th datta lecture. TFIIH: from transcription to clinic
FEBS Lett.
The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II
Mol. Cell
SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase
J. Biol. Chem.
Chromatin remodeling enzymes: who's on first?
Curr. Biol.
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists
Chem. Biol.
Down-regulation of the phosphatidylinositol 3-Kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2
J. Biol. Chem.
The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers
J. Biol. Chem.
The bromodomain revisited
Trends Biochem. Sci.
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
Cell
Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex
J. Biol. Chem.
XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha
Cell
Nuclear-receptor interactions on DNA-response elements
Trends Biochem. Sci.
Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin–proteasome pathway
J. Biol. Chem.
Histone methylation in transcriptional control
Curr. Opin. Genet. Dev.
Stress pathway activation induces phosphorylation of retinoid X receptor
J. Biol. Chem.
Multiplicity generates diversity in the retinoic acid signalling pathways
Trends Biochem. Sci.
Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells
J. Biol. Chem.
Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity
J. Biol. Chem.
Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells
Trends Biochem. Sci.
The RXR heterodimers and orphan receptors
Cell
A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
Cell
Combinatorial control of gene expression by nuclear receptors and coregulators
Cell
A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains
Mol. Cell
The nuclear receptor ligand-binding domain: structure and function
Curr. Opin. Cell Biol.
Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors
Cell
Cooperation between complexes that regulate chromatin structure and transcription
Cell
A unified theory of gene expression
Cell
The promise of retinoids to fight against cancer
Nat. Rev., Cancer
Cited by (632)
Molecular characterization and potential function of Rxrγ in gonadal differentiation of Chinese soft-shelled turtle (Pelodiscus sinensis)
2023, Journal of Steroid Biochemistry and Molecular BiologyEndocrine disrupting activity in sewage sludge: Screening method, microbial succession and cost-effective strategy for detoxification
2023, Journal of Environmental ManagementUse of vitamins and minerals as dietary supplements for better health and cancer prevention
2023, Nutraceuticals: Sources, Processing Methods, Properties, and Applications